K Pharma (TSE:4896) Receivables Turnover: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4896 K Pharma Inc TSE:4896
11 GF Score
Price 円812.00
! 1 Warning Sign
View Full Analysis

What is K Pharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. K Pharma's Revenue for the three months ended in Jun. 2026 was 円0.00 Mil. K Pharma's average Accounts Receivable for the three months ended in Jun. 2026 was 円0.00 Mil.

K Pharma  (TSE:4896) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

K Pharma Receivables Turnover Related Terms

K Pharma Receivables Turnover Historical Data

* Premium members only.

The historical data trend for K Pharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma Receivables Turnover Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Receivables Turnover
- - - - -

K Pharma Quarterly Data
Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TSE:4896 vs VRTX, REGN, MRNA: Receivables Turnover Comparison

For the Biotechnology subindustry, K Pharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

K Pharma Receivables Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, K Pharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where K Pharma's Receivables Turnover falls into.


TSE:4896
11GF Score
K Pharma Inc TSE:4896
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

K Pharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

K Pharma's Receivables Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Receivables Turnover (A: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2025 ) / ((Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count )
=0 / (( + ) / 1 )
=0 / 0
=N/A

K Pharma's Receivables Turnover for the quarter that ended in Jun. 2026 is calculated as

Receivables Turnover (Q: Jun. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Jun. 2026 ) / ((Accounts Receivable (Q: Mar. 2026 ) + Accounts Receivable (Q: Jun. 2026 )) / count )
=0 / (( + ) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma Business Description

Address 7-7-7 Roppongi, Tri-Seven Roppongi 8th Floor, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
11GF Score

Get the complete analysis for TSE:4896

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円812.00
Price